19 June 2013
Keywords: adherex, adds, sites, ph, ii, adh-1, trial
Article | 08 August 2005
Adherex Technologies, a US biopharmaceutical company with a broad portfolio of oncology products under development, says that it has
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 August 2005
18 June 2013
© 2013 thepharmaletter.com